| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8721454 | Clinical Immunology | 2018 | 5 Pages |
Abstract
Early treatment determines early clinical improvement, treatment-to-target determines long term outcomes. Prevention of relevant radiologic damage progression and disability, drug free remission and normalized survival are realistic goals.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Cornelia F. Allaart, Iris M. Markusse, Willem F. Lems,